Reducing the Risk of Pancreatitis by Inhibiting APOC3

Nathan O. Stitziel

doi:10.1056/nejme2411605

January 8, 2025New England Journal of Medicine

Reducing the Risk of Pancreatitis by Inhibiting APOC3

View at Publisher

Ask AI

Bookmark

Share

Why the study?

Does inhibiting APOC3 reduce the risk of pancreatitis in patients with extreme hypertriglyceridemia?

Structured PICO

Does inhibiting APOC3 reduce the risk of pancreatitis in patients with extreme hypertriglyceridemia?

P

Population

Persons with extreme hypertriglyceridemia (plasma triglycerides >880 mg/dL), including familial chylomicronemia syndrome (FCS) and multifactorial chylomicronemia syndrome (MCS)

I

Intervention

Inhibiting APOC3

O

Outcome

Reducing the risk of pancreatitis

Implication

Discusses the potential of APOC3 inhibition to reduce pancreatitis risk in patients with extreme hypertriglyceridemia syndromes.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nathan O. Stitziel (2025) studied this question.

synapsesocial.com/papers/6a907ca573c1f5e62dc937d7 https://doi.org/10.1056/nejme2411605

View at Publisher

Ask AI

Bookmark

Share

Reducing the Risk of Pancreatitis by Inhibiting APOC3

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Reducing the Risk of Pancreatitis by Inhibiting APOC3

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from New England Journal of Medicine

Keep reading

More related papers

More from New England Journal of Medicine